Increased expression of IGF2BP1 correlated significantly with the tumor size, lymph node metastasis, distant metastasis, and clinical stage grade (Fig. 4J, K and Fig. S5C, D). The gene discussed is IGF2BP1; the disease is metastatic malignant neoplasm in the lymph nodes.